Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects☆
To access this article, please choose from the options below
☆ Supported by grants from the Fondo de Investigacion Sanitaria, the Spanish Ministry of Health, and the Xunta de Galicia.
PII: 0026-0495(95)90187-6
© 1995 Published by Elsevier Inc.
